Hsp90. A Global Regulator of the Genotype-to-Phenotype Map in Cancers

Advances in Cancer Research

Volumn 129, Issue , 2016, Pages 225-247

  Jarosz, Daniel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer therapeutics; Chaperone; Disease evolution; Epigenetics; Hsp90; Protein folding

Indexed keywords

HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; TRANSCRIPTION FACTOR;

BREAST CANCER; CANCER CELL; CANCER GENETICS; CANCER PROGNOSIS; CANCER THERAPY; ENVIRONMENTAL STRESS; EPIGENETICS; GAIN OF FUNCTION MUTATION; GENE MAPPING; GENETIC VARIABILITY; GENETIC VARIATION; GENOTYPE; HUMAN; LUNG CANCER; NONHUMAN; PENETRANCE; PHENOTYPE; POSTTRANSCRIPTIONAL GENE SILENCING; PROSTATE CANCER; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN STRUCTURE; TRANSFORMED CELL; ANIMAL; GENETIC EPIGENESIS; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; METABOLISM; MUTATION; NEOPLASM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; EPIGENESIS, GENETIC; GENE-ENVIRONMENT INTERACTION; GENETIC VARIATION; GENOTYPE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MUTATION; NEOPLASMS; PENETRANCE; PROTEIN FOLDING; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTORS;

EID: 84969504514     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.acr.2015.11.001     Document Type: Chapter

References (107)

1. Aligue R., Akhavan-Niak H., Russell P. A role for Hsp90 in cell cycle control: Wee1 tyrosine kinase activity requires interaction with Hsp90. The EMBO Journal 1994, 13:6099-6106.
2. Bali P., Pranpat M., Bradner J., Balasis M., Fiskus W., Guo F., et al. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: A novel basis for antileukemia activity of histone deacetylase inhibitors. The Journal of Biological Chemistry 2005, 280:26729-26734.
3. Barkai N., Leibler S. Robustness in simple biochemical networks. Nature 1997, 387:913-917.
4. Berg J.M., Tymoczko J.L., Stryer L. Biochemistry 2006, W.H. Freeman, New York. 6th ed.
5. Bergman A., Siegal M.L. Evolutionary capacitance as a general feature of complex gene networks. Nature 2003, 424:549-552.
6. Bershtein S., Segal M., Bekerman R., Tokuriki N., Tawfik D. Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein. Nature 2006, 444:929-932.
7. Bloom J.D., Labthavikul S.T., Otey C.R., Arnold F.H. Protein stability promotes evolvability. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:5869-5874.
8. Bloom J.D., Wilke C.O., Arnold F.H., Adami C. Stability and the evolvability of function in a model protein. Biophysical Journal 2004, 86:2758-2764.
9. Borkovich K.A., Farrelly F.W., Finkelstein D.B., Taulien J., Lindquist S. hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Molecular and Cellular Biology 1989, 9:3919-3930.
10. Boyault C., Sadoul K., Pabion M., Khochbin S. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Oncogene 2007, 26:5468-5476.
11. Brem R.B., Yvert G., Clinton R., Kruglyak L. Genetic dissection of transcriptional regulation in budding yeast. Science 2002, 296:752-755.
12. Burga A., Casanueva M.O., Lehner B. Predicting mutation outcome from early stochastic variation in genetic interaction partners. Nature 2011, 480:250-253.
13. Carey N., La Thangue N.B. Histone deacetylase inhibitors: Gathering pace. Current Opinion in Pharmacology 2006, 6:369-375.
14. Casanueva M.O., Burga A., Lehner B. Fitness trade-offs and environmentally induced mutation buffering in isogenic C. Elegans. Science 2012, 335:82-85.
15. Cassidy J.J., Jha A.R., Posadas D.M., Giri R., Venken K.J., Ji J., et al. miR-9a minimizes the phenotypic impact of genomic diversity by buffering a transcription factor. Cell 2013, 155:1556-1567.
16. Chen G., Bradford W.D., Seidel C.W., Li R. Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature 2012, 482:246-250.
17. Citri A., Harari D., Shohat G., Ramakrishnan P., Gan J., Lavi S., et al. Hsp90 recognizes a common surface on client kinases. The Journal of Biological Chemistry 2006, 281:14361-14369. (Supplementary Data).
18. Cowen L.E. Hsp90 orchestrates stress response signaling governing fungal drug resistance. PLoS Pathogens 2009, 5:e1000471.
19. Cowen L.E., Carpenter A.E., Matangkasombut O., Fink G.R., Lindquist S. Genetic architecture of Hsp90-dependent drug resistance. Eukaryotic Cell 2006, 5:2184-2188.
20. Cowen L.E., Lindquist S. Hsp90 potentiates the rapid evolution of new traits: Drug resistance in diverse fungi. Science 2005, 309:2185-2189.
21. Depristo M.A., Weinreich D.M., Hartl D.L. Missense meanderings in sequence space: A biophysical view of protein evolution. Nature Reviews. Genetics 2005, 6:678-687.
22. Doucet-O'Hare T.T., Rodic N., Sharma R., Darbari I., Abril G., Choi J.A., et al. LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2015, 112:E4894-E4900.
23. Drysdale M.J., Brough P.A., Massey A., Jensen M.R., Schoepfer J. Targeting Hsp90 for the treatment of cancer. Current Opinion in Drug Discovery & Development 2006, 9:483-495.
24. Falsone S.F., Leptihn S., Osterauer A., Haslbeck M., Buchner J. Oncogenic mutations reduce the stability of SRC kinase. Journal of Molecular Biology 2004, 344:281-291.
25. Fares M.A., Barrio E., Sabater-Munoz B., Moya A. The evolution of the heat-shock protein GroEL from Buchnera, the primary endosymbiont of aphids, is governed by positive selection. Molecular Biology and Evolution 2002, 19:1162-1170.
26. Fersht A.R. Structure and mechanism in protein science: A guide to enzyme catalysis and protein folding 1998, W.H. Freeman, New York. 1st ed.
27. Gangaraju V.K., Yin H., Weiner M.M., Wang J., Huang X.A., Lin H. Drosophila Piwi functions in Hsp90-mediated suppression of phenotypic variation. Nature Genetics 2011, 43:153-158.
28. Gibson G., Dworkin I. Uncovering cryptic genetic variation. Nature Reviews. Genetics 2004, 5:681-690.
29. Haarberg H.E., Paraiso K.H., Wood E., Rebecca V.W., Sondak V.K., Koomen J.M., et al. Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma. Molecular Cancer Therapeutics 2013, 12:901-912.
30. Ichiyanagi T., Ichiyanagi K., Ogawa A., Kuramochi-Miyagawa S., Nakano T., Chuma S., et al. HSP90alpha plays an important role in piRNA biogenesis and retrotransposon repression in mouse. Nucleic Acids Research 2014, 42:11903-11911.
31. Iki T., Yoshikawa M., Nishikiori M., Jaudal M.C., Matsumoto-Yokoyama E., Mitsuhara I., et al. In vitro assembly of plant RNA-induced silencing complexes facilitated by molecular chaperone HSP90. Molecular Cell 2010, 39:282-291.
32. Iwai A., Bourboulia D., Mollapour M., Jensen-Taubman S., Lee S., Donnelly A.C., et al. Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle 2012, 11:3649-3655.
33. Jarosz D.F., Lancaster A.K., Brown J.C.S., Lindquist S. An evolutionarily conserved epigenetic element converts wild fungi from metabolic specialists to generalists. Cell 2014, 158:1072-1082.
34. Jarosz D.F., Lindquist S. Hsp90 and environmental stress transform the adaptive value of natural genetic variation. Science 2010, 330:1820-1824.
35. Jarosz D.F., Taipale M., Lindquist S. Protein homeostasis and the phenotypic manifestation of genetic diversity: Principles and mechanisms. Annual Review of Genetics 2010, 44:189-216.
36. Kovacs J.J., Murphy P.J., Gaillard S., Zhao X., Wu J.T., Nicchitta C.V., et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Molecular Cell 2005, 18:601-607.
37. Li Y., Li W., Ying Z., Tian H., Zhu X., Li J., et al. Metastatic heterogeneity of breast cancer cells is associated with expression of a heterogeneous TGFbeta-activating miR424-503 gene cluster. Cancer Research 2014, 74:6107-6118.
38. Lindquist S.L., Craig E.A. The heat-shock proteins. Annual Review of Genetics 1988, 22:631-677.
39. Lu X., Wang L., Ruden D.M. Hsp90 inhibitors and the reduction of anti-cancer drug resistance by non-genetic and genetic mechanisms. Pharmaceuticals 2012, 5:890-898.
40. Maisnier-Patin S., Roth J.R., Fredriksson A., Nystrom T., Berg O.G., Andersson D.I. Genomic buffering mitigates the effects of deleterious mutations in bacteria. Nature Genetics 2005, 37:1376-1379.
41. Masel J., Trotter M.V. Robustness and evolvability. Trends in Genetics 2010, 26:406-414.
42. McClellan A.J., Xia Y., Deutschbauer A.M., Davis R.W., Gerstein M., Frydman J. Diverse cellular functions of the hsp90 molecular chaperone uncovered using systems approaches. Cell 2007, 131:121-135.
43. Mendillo M.L., Santagata S., Koeva M., Bell G.W., Hu R., Tamimi R.M., et al. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell 2012, 150:549-562.
44. Millson S.H., Truman A.W., King V., Prodromou C., Pearl L.H., Piper P.W. A two-hybrid screen of the yeast proteome for Hsp90 interactors uncovers a novel Hsp90 chaperone requirement in the activity of a stress-activated mitogen-activated protein kinase, Slt2p (Mpk1p). Eukaryotic Cell 2005, 4:849-860.
45. Milton C.C., Ulane C.M., Rutherford S. Control of canalization and evolvability by Hsp90. PloS One 2006, 1:e75.
46. Miyoshi T., Takeuchi A., Siomi H., Siomi M.C. A direct role for Hsp90 in pre-RISC formation in Drosophila. Nature Structural & Molecular Biology 2010, 17:1024-1026.
47. Neckers L. Heat shock protein 90: The cancer chaperone. Journal of Biosciences 2007, 32:517-530.
48. Nolan K.D., Franco O.E., Hance M.W., Hayward S.W., Isaacs J.S. Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion. The Journal of Biological Chemistry 2015, 290:8271-8282.
49. Oliver A., Canton R., Campo P., Baquero F., Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288:1251-1254.
50. Perlstein E.O., Ruderfer D.M., Roberts D.C., Schreiber S.L., Kruglyak L. Genetic basis of individual differences in the response to small-molecule drugs in yeast. Nature Genetics 2007, 39:496-502.
51. Piacentini L., Fanti L., Specchia V., Bozzetti M.P., Berloco M., Palumbo G., et al. Transposons, environmental changes, and heritable induced phenotypic variability. Chromosoma 2014, 123:345-354.
52. Picard D., Khursheed B., Garabedian M.J., Fortin M.G., Lindquist S.L., Yamamoto K.R. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 1990, 348:166-168.
53. Posadas D.M., Carthew R.W. MicroRNAs and their roles in developmental canalization. Current Opinion in Genetics & Development 2014, 27:1-6.
54. Queitsch C., Sangster T.A., Lindquist S.L. Hsp90 as a capacitor of phenotypic variation. Nature 2002, 417:618-624.
55. Rodic N., Burns K.H. Long interspersed element-1 (LINE-1): Passenger or driver in human neoplasms?. PLoS Genetics 2013, 9:e1003402.
56. Rodic N., Sharma R., Sharma R., Zampella J., Dai L., Taylor M.S., et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. The American Journal of Pathology 2014, 184:1280-1286.
57. Rodic N., Steranka J.P., Makohon-Moore A., Moyer A., Shen P., Sharma R., et al. Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma. Nature Medicine 2015, 21:1060-1064.
58. Rohner N., Jarosz D.F., Kowalko J.E., Yoshizawa M., Jeffery W.R., Borowsky R.L., et al. Cryptic variation in morphological evolution: HSP90 as a capacitor for loss of eyes in cavefish. Science 2013, 342:1372-1375.
59. Ruden D.M., Garfinkel M.D., Sollars V.E., Lu X. Waddington's widget: Hsp90 and the inheritance of acquired characters. Seminars in Cell & Developmental Biology 2003, 14:301-310.
60. Rutherford S.L., Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature 1998, 396:336-342.
61. Sahni N., Yi S., Taipale M., Fuxman Bass J.I., Coulombe-Huntington J., Yang F., et al. Widespread macromolecular interaction perturbations in human genetic disorders. Cell 2015, 161:647-660.
62. Salathia N., Lee H.N., Sangster T.A., Morneau K., Landry C.R., Schellenberg K., et al. Indel arrays: An affordable alternative for genotyping. The Plant Journal 2007, 51:727-737.
63. Salathia N., Queitsch C. Molecular mechanisms of canalization: Hsp90 and beyond. Journal of Biosciences 2007, 32:457-463.
64. Sangster T.A., Bahrami A., Wilczek A., Watanabe E., Schellenberg K., McLellan C., et al. Phenotypic diversity and altered environmental plasticity in Arabidopsis thaliana with reduced Hsp90 levels. PloS One 2007, 2:e648.
65. Sangster T.A., Lindquist S.L., Queitsch C. Under cover: Causes, effects and implications of Hsp90-mediated genetic capacitance. Bioessays 2004, 26:348-362.
66. Sangster T.A., Salathia N., Lee H.N., Watanabe E., Schellenberg K., Morneau K., et al. HSP90-buffered genetic variation is common in Arabidopsis thaliana. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2969-2974.
67. Santagata S., Hu R., Lin N.U., Mendillo M.L., Collins L.C., Hankinson S.E., et al. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:18378-18383.
68. Sawai A., Chandarlapaty S., Greulich H., Gonen M., Ye Q., Arteaga C.L., et al. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Cancer Research 2008, 68:589-596.
69. Sawarkar R., Paro R. Hsp90@chromatin.nucleus: An emerging hub of a networker. Trends in Cell Biology 2013, 23:193-201.
70. Sawarkar R., Sievers C., Paro R. Hsp90 globally targets paused RNA polymerase to regulate gene expression in response to environmental stimuli. Cell 2012, 149:807-818.
71. Scroggins B.T., Robzyk K., Wang D., Marcu M.G., Tsutsumi S., Beebe K., et al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Molecular Cell 2007, 25:151-159.
72. Sekimoto T., Oda T., Pozo F.M., Murakumo Y., Masutani C., Hanaoka F., et al. The molecular chaperone Hsp90 regulates accumulation of DNA polymerase eta at replication stalling sites in UV-irradiated cells. Molecular Cell 2010, 37:79-89.
73. Serrano L., Day A.G., Fersht A.R. Step-wise mutation of barnase to binase. A procedure for engineering increased stability of proteins and an experimental analysis of the evolution of protein stability. Journal of Molecular Biology 1993, 233:305-312.
74. Shah N., Sukumar S. The Hox genes and their roles in oncogenesis. Nature Reviews. Cancer 2010, 10:361-371.
75. Shapiro R.S., Uppuluri P., Zaas A.K., Collins C., Senn H., Perfect J.R., et al. Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Current Biology: CB 2009, 19:621-629.
76. Smith D.F., Toft D.O. The intersection of steroid receptors with molecular chaperones: Observations and questions. Molecular Endocrinology 2008, 22:2229-2240.
77. Sollars V., Lu X., Xiao L., Wang X., Garfinkel M.D., Ruden D.M. Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nature Genetics 2003, 33:70-74.
78. Sos M.L., Michel K., Zander T., Weiss J., Frommolt P., Peifer M., et al. Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. The Journal of Clinical Investigation 2009, 119:1727-1740.
79. Specchia V., Piacentini L., Tritto P., Fanti L., D'Alessandro R., Palumbo G., et al. Hsp90 prevents phenotypic variation by suppressing the mutagenic activity of transposons. Nature 2010, 463:662-665.
80. Suzuki R., Honda S., Kirino Y. PIWI expression and function in cancer. Frontiers in Genetics 2012, 3:204.
81. Taipale M., Jarosz D.F., Lindquist S. HSP90 at the hub of protein homeostasis: Emerging mechanistic insights. Nature Reviews. Molecular Cell Biology 2010, 11:515-528.
82. Taipale M., Krykbaeva I., Koeva M., Kayatekin C., Westover K.D., Karras G.I., et al. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell 2012, 150:987-1001.
83. Taldone T., Ochiana S.O., Patel P.D., Chiosis G. Selective targeting of the stress chaperome as a therapeutic strategy. Trends in Pharmacological Sciences 2014, 35:592-603.
84. Tarafa G., Tuck D., Ladner D., Topazian M., Brand R., Deters C., et al. Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:4306-4311.
85. Tariq M., Nussbaumer U., Chen Y., Beisel C., Paro R. Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:1157-1162.
86. Trepel J., Mollapour M., Giaccone G., Neckers L. Targeting the dynamic HSP90 complex in cancer. Nature Reviews. Cancer 2010, 10:537-549.
87. Tsutsumi S., Beebe K., Neckers L. Impact of heat-shock protein 90 on cancer metastasis. Future Oncology 2009, 5:679-688.
88. Vincent B.M., Lancaster A.K., Scherz-Shouval R., Whitesell L., Lindquist S. Fitness trade-offs restrict the evolution of resistance to amphotericin B. PLoS Biology 2013, 11:e1001692.
89. Waddington C.H. Canalization of development and the inheritance of acquired characters. Nature 1942, 150:563-565.
90. Waddington C.H. Genetic assimilation of an acquired character. Evolution 1953, 7:118-126.
91. Waddington C.H. Genetic assimilation of the bithorax phenotype. Evolution 1956, 10:1-13.
92. Waddington C.H. Canalization of development and genetic assimilation of acquired characters. Nature 1959, 183:1654-1655.
93. Wang Z., Moult J. SNPs, protein structure, and disease. Human Mutation 2001, 17:263-270.
94. Wang Y., Trepel J.B., Neckers L.M., Giaccone G. STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer. Current Opinion in Investigational Drugs 2010, 11:1466-1476.
95. Weick E.M., Miska E.A. PiRNAs: From biogenesis to function. Development 2014, 141:3458-3471.
96. White T.C. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrobial Agents and Chemotherapy 1997, 41:1482-1487.
97. Whitesell L., Mimnaugh E.G., De Costa B., Myers C.E., Neckers L.M. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: Essential role for stress proteins in oncogenic transformation. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:8324-8328.
98. Xiol J., Cora E., Koglgruber R., Chuma S., Subramanian S., Hosokawa M., et al. A role for Fkbp6 and the chaperone machinery in piRNA amplification and transposon silencing. Molecular Cell 2012, 47:970-979.
99. Xu Y., Lindquist S.L. Heat-shock protein hsp90 governs the activity of pp60v-src kinase. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:7074-7078.
100. Xu W., Neckers L. Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2007, 13:1625-1629.
101. Xu Y., Singer M.A., Lindquist S.L. Maturation of the tyrosine kinase c-src as a kinase and as a substrate depends on the molecular chaperone Hsp90. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:109-114.
102. Xu W., Soga S., Beebe K., Lee M.J., Kim Y.S., Trepel J., et al. Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition. British Journal of Cancer 2007, 97:741-744.
103. Yeyati P.L., Bancewicz R.M., Maule J., van Heyningen V. Hsp90 selectively modulates phenotype in vertebrate development. PLoS Genetics 2007, 3:e43.
104. Young J.C., Agashe V.R., Siegers K., Hartl F.U. Pathways of chaperone-mediated protein folding in the cytosol. Nature Reviews. Molecular Cell Biology 2004, 5:781-791.
105. Zhao R., Davey M., Hsu Y.C., Kaplanek P., Tong A., Parsons A.B., et al. Navigating the chaperone network: An integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell 2005, 120:715-727.
106. Zhao R., Houry W.A. Hsp90: A chaperone for protein folding and gene regulation. Biochemistry and Cell Biology 2005, 83:703-710.
107. Zhao R., Kakihara Y., Gribun A., Huen J., Yang G., Khanna M., et al. Molecular chaperone Hsp90 stabilizes Pih1/Nop17 to maintain R2TP complex activity that regulates snoRNA accumulation. The Journal of Cell Biology 2008, 180:563-578.